Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
ATC Code
R03AK07
Source
EMA · EMEA/H/C/002348
(
ARTG
)
Asthma: DuoResp Spiromax is indicated in adults (18 years and older) for the treatment of asthma, to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations (see Section 4.2 Dose and method of administration).,DuoResp Spiromax is not indicated in children and adolescents under the age of 18 years as the 100/6 dose is not available.,Chronic Obstructive Pulmonary Disease (COPD):
DuoResp Spiromax is indicated for the symptomatic treatment of moderate to severe COPD (FEV1=50% predicted normal) in adults with frequent symptoms despite long-acting bronchodilator use, and/or history of recurrent exacerbations. DuoResp Spiromax is not indicated for the initiation of bronchodilator therapy in COPD.
⚠️ Warnings
•
♦
Caution should be exercised in patients with history of irregular heartbeat, high blood pressure, epilepsy, diabetes, any allergy,
aneurism and pheochromocytoma
, who are taking other medications especially other asthma medicines, heart or thyroid disease, elderly, children, during pregnancy and breastfeeding.
• It may cause dizziness, do not drive a car or operate machinery while taking this medication.
♦
Patient may develop with increased risk of serious heart problems and
asthma-related death
; if it so consult with your doctor.
• Do not use more than recommended dose.
• If there is no improvement in patient's condition, consult with your doctor.
PillsCard reference image